In this research, we discovered that a transcript factor, hepatocyte nuclear factor 4 gamma (HNF4G), significantly increases cisplatin’s resistance in lung adenocarcinoma by upregulating the MAPK6/Akt signaling pathway. The gene discussed is MAPK6; the disease is lung adenocarcinoma.